Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

LAUNXP BIOMEDICAL CO., LTD. (6876) Financial Statements

LAUNXP BIOMEDICAL CO., LTD. Financial Overview

LAUNXP BIOMEDICAL CO., LTD.'s market cap is currently NT$990.93M. The company's EPS TTM is NT$-7.90; its P/E ratio is -1.78; LAUNXP BIOMEDICAL CO., LTD. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 0.00NT$ 2.48MNT$ 11.00KNT$ 0.00NT$ 0.00
Gross ProfitNT$ -2.52MNT$ 2.29MNT$ 11.00KNT$ 0.00NT$ 0.00
Operating IncomeNT$ -110.93MNT$ -82.30MNT$ -81.05MNT$ -43.42MNT$ -34.69M
EBITDANT$ -108.40MNT$ -79.65MNT$ -78.37MNT$ -41.07MNT$ -33.08M
Net IncomeNT$ -110.01MNT$ -82.59MNT$ -80.95MNT$ -43.61MNT$ -34.75M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 50.03MNT$ 98.37MNT$ 179.73MNT$ 15.20MNT$ 61.12M
Total AssetsNT$ 403.03MNT$ 123.91MNT$ 206.49MNT$ 32.44MNT$ 73.88M
Total DebtNT$ 19.57MNT$ 2.41MNT$ 2.65MNT$ 3.57MNT$ 5.14M
Net DebtNT$ -30.46MNT$ -95.96MNT$ -177.09MNT$ -11.63MNT$ -28.98M
Total LiabilitiesNT$ 151.38MNT$ 15.05MNT$ 23.19MNT$ 10.23MNT$ 8.65M
Stockholders' EquityNT$ 251.65MNT$ 108.86MNT$ 183.30MNT$ 22.21MNT$ 65.23M
Cash Flow
Free Cash FlowNT$ -136.86MNT$ -76.97MNT$ -62.45MNT$ -45.02MNT$ -33.24M
Operating Cash FlowNT$ -134.98MNT$ -76.66MNT$ -59.14MNT$ -44.21MNT$ -28.99M
Investing Cash FlowNT$ -162.77MNT$ -326.00KNT$ -3.31MNT$ 26.20MNT$ -4.35M
Financing Cash FlowNT$ 248.81MNT$ -4.38MNT$ 226.98MNT$ -900.00KNT$ 35.53M

Currency in TWD

LAUNXP BIOMEDICAL CO., LTD. Earnings and Revenue History

-120M-60M060M-900000 %-600000 %-300000 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

LAUNXP BIOMEDICAL CO., LTD. Liabilities to Assets

0150M300M450M0 %15 %30 %45 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

LAUNXP BIOMEDICAL CO., LTD. Cash Flow

-200M-100M0100M200M300M202020212022202320242025OperatingInvestingFinancing
Cash Flow >

LAUNXP BIOMEDICAL CO., LTD. Forecast EPS vs Actual EPS

Earnings >